A novel nasal spray combines a common antibiotic with a well-known antioxidant and human trials are set to begin soon
the staff of the Ridgewood blog
Ridgewood NJ, a novel nasal spray designed to prevent the neurodegeneration associated with dementia has shown promising results in mouse studies. The spray is a combination of two pre-existing drugs. Mice with neurodegenerative diseases showed improved cognition and less accumulation of toxic proteins in the brain after the spray was intranasally administered five times a week for a month. The combination of drugs was more effective at preventing neurodegeneration than each drug by itself. Human trials will start soon in several countries, including Japan and the US.
